At the time of writing, Kronos Bio Inc [KRON] stock is trading at $0.96, up 10.99%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KRON shares have gain 11.64% over the last week, with a monthly amount drifted -2.13%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kronos Bio Inc [NASDAQ: KRON] stock has seen the most recent analyst activity on November 14, 2024, when TD Cowen downgraded its rating to a Hold. Previously, Piper Sandler downgraded its rating to Neutral on November 14, 2024, and dropped its price target to $1. On September 14, 2022, Berenberg initiated with a Buy rating and assigned a price target of $12 on the stock. H.C. Wainwright initiated its recommendation with a Buy and recommended $35 as its price target on June 24, 2021. Piper Sandler started tracking with a Overweight rating for this stock on November 03, 2020, and assigned it a price target of $50. In a note dated November 03, 2020, Jefferies initiated an Buy rating and provided a target price of $36 on this stock.
For the past year, the stock price of Kronos Bio Inc fluctuated between $0.69 and $1.60. Currently, Wall Street analysts expect the stock to reach $1.63 within the next 12 months. Kronos Bio Inc [NASDAQ: KRON] shares were valued at $0.96 at the most recent close of the market. An investor can expect a potential return of 69.79% based on the average KRON price forecast.
Analyzing the KRON fundamentals
According to Kronos Bio Inc [NASDAQ:KRON], the company’s sales were 9.86M for trailing twelve months, which represents an 158.45% jump. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at -8.14%, Pretax Profit Margin comes in at -8.68%, and Net Profit Margin reading is -8.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.57, Equity is -0.65 and Total Capital is -0.6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.9234 points at the first support level, and at 0.8868 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.9933, and for the 2nd resistance point, it is at 1.0266.
Ratios To Look Out For
It is important to note that Kronos Bio Inc [NASDAQ:KRON] has a current ratio of 8.32. As well, the Quick Ratio is 8.32, while the Cash Ratio is 4.87. Considering the valuation of this stock, the price to sales ratio is 6.52, the price to book ratio is 0.52.
Transactions by insiders
Recent insider trading involved BISCHOFBERGER NORBERT W, PRESIDENT & CEO, that happened on Jun 27 ’24 when 0.41 million shares were purchased. PRESIDENT & CEO, BISCHOFBERGER NORBERT W completed a deal on Jun 28 ’24 to buy 0.2 million shares. Meanwhile, PRESIDENT & CEO BISCHOFBERGER NORBERT W bought 1.38 million shares on Jun 10 ’24.
